1  2  3  4  5    
The Online Metabolic and Molecular Bases of Inherited Disease, 8th Edition
David Valle, William Sly, Arthur Beaudet, Charles Scriver

Under the experienced editorial leadership of world class investigators and recognized experts in genetics, OMMBID expands and updates content from internationally acclaimed researchers and clinicians.

Contributions from genetics are changing the way physicians diagnose, and OMMBID provides a strong clinical component including information on diagnosis, testing and screening, genetic counseling, and gene therapy. OMMBID - your resource repository for genomics and pharmacogenomics.

The site's streamlined organization and flexible navigation tools help optimize your use of this one-stop reference. Hyperlinked tables of contents and a robust search engine facilitate access to topics of interest. While delivering daily medical news, the home page also gives you access to hot topics, discussion groups, and the site's generous amount of dynamic content and media, including these features:

  • Full search capabilities powered by Google TM
  • New supplemental material available only online!
  • Including:
    • Gene Expression Profiling in Cancer
    • Hereditary Paragangliomas of the Head and Neck
    • Familial Cylindromatosis
    • Familial Cardiac Myxomas and Carney Complex
    • Cancers of the Oral Cavity and Pharynx
    • Genetic Abnormalities in Lymphoid Malignancies
    • Pilomatricoma and Pilomatrix Carcinom
  • Easy Navigation for Quick Answers
    Scrolling menus and cross-referenced content
  • Excellent Search and Multimedia Tools
    Fast engine for precise results
  • Complex Illustrations
    Full color figures and 3D representations
  • Search related sites easily
    Including OMIM, PubMed, GeneReviews and others...
[ Top ]
Therapeutic Advisory Group

TAG is an independent, not-for-profit group of clinical pharmacologists, pharmacists and clinicians committed to the promotion of quality drug use in hospitals and the wider community. NSW TAG's fundamental goal is to promote quality use of medicines in NSW hospitals ie use of medicines which is judicious, appropriate, safe and efficacious. Our major strategy is to provide support for hospital Drug and Therapeutics Committees, as they influence prescribing and drug use within hospitals. We also have developed strategic links with relevant organisations to address the quality use of medicines across the hospital/community interface.

[ Top ]
Understanding Health Policy A Clinical Approach, 4th Edition
Kevin Grumbach, Thomas Bodenheimer

The #1 text on health policy, this well-known resource provides a short introduction to U.S. health care policy by two leading experts who are themselves practicing physicians.

It features the latest information on cost containment, health insurance, managed care, hospital payment, and the new two-tier model of physician reimbursement.

[ Top ]
Vanders Renal Physiology, 6th Edition
John Pooler, Douglas Eaton

This concise overview of renal physiology introduces basic science principles and their relevance in the clinical expression of disease.

Each chapter incorporates a wealth of pedagogical aids including: study questions, learning objectives, and clinical examples. Also serves as a good review for the USMLE Step 1.

[ Top ]
Vaughan and Asbury's General Ophthalmology, 16th Edition
John Whitcher, Paul Riordan-Eva

The world's most popular ophthalmology text!

Thoroughly updated, this resource covers the state-of-the-art diagnosis and treatment of all major diseases and disorders of the eye in adults and children. Generously illustrated with high quality clinical photographs and excellent drawings. Includes high-tech diagnostic and therapeutic information as well as a comprehensive glossary and handy, easy-to-use tables.

[ Top ]
RANZCP Clinical Practice Guidelines
Royal Australian and New Zealand College of Psychiatrists

The RANZCP has developed Clinical Practice Guidelines (CPGs) to provide mental health practitioners, consumers, and carers with evidence-based information about particular mental illnesses and appropriate treatment options. These have been developed with the support of both the Australian and New Zealand Governments.

The CPGs address six specific disorders or conditions that have considerable impact on psychiatric practice in Australia and New Zealand, as expressed from both the psychiatric profession and consumers. These are:

  • anorexia nervosa;
  • bipolar disorder;
  • deliberate self harm (youth and adult);
  • depression;
  • panic disorder and agoraphobia; and
  • schizophrenia.

For each disorder or condition, two Guidelines have been developed – one for consumers and carers, and one for mental health clinicians (summary and full versions). Links to the Guidelines are provided below.

The CPGs:

  • systematically evaluate research evidence;
  • were developed by representatives from a range of professional groups, as well as consumers;
  • are specifically designed to assist, rather than dictate, clinical decision-making; and
  • are to be applied on a case-by-case basis.

The Guidelines are current at the time of publication, but because they are evidence-based, they will inevitably become out of date as new research emerges regarding established and novel treatments. Therefore a crucial aspect of implementing the Guidelines will be ensuring that they are reviewed on a regular basis.

[ Top ]
   1  2  3  4  5